- Home
- SSII vs BME Comparison
SSII vs BME Comparison
Compare SSII & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SSII | BME |
|---|---|---|
| Founded | N/A | N/A |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | | Trusts Except Educational Religious and Charitable |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 655.3M | 576.8M |
| IPO Year | 2017 | 2005 |
Fundamental Metrics
Financial Performance| Metric | SSII | BME |
|---|---|---|
| Price | $2.30 | $46.90 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 53.9K | 37.4K |
| Earning Date | 11-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.45 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $42,484,747.00 | N/A |
| Revenue This Year | $40.29 | N/A |
| Revenue Next Year | $27.85 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 105.74 | N/A |
| 52 Week Low | $2.20 | $37.51 |
| 52 Week High | $8.20 | $46.75 |
Technical Indicators
Market Signals| Indicator | SSII | BME |
|---|---|---|
| Relative Strength Index (RSI) | 37.58 | 67.98 |
| Support Level | $2.20 | $41.77 |
| Resistance Level | $4.16 | N/A |
| Average True Range (ATR) | 0.23 | 0.70 |
| MACD | 0.02 | 0.26 |
| Stochastic Oscillator | 34.67 | 84.20 |
Price Performance
Historical ComparisonAbout SSII SS Innovations International Inc.
SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.